Genoskin attended the 9th World Congress On Alternatives and Animal Use in The Life Sciences (WC9 2014) organized in Prague, Czech Republic, from the 24 to the 28 August. “The world congress provides an exceptional forum to underline the importance of both the ethical issues of animal experimentation and the approach to the life sciences in the 21st century.”
Genoskin has presented its ex vivo human skin explant model, NativeSkin®, during labcourses focused on skin drug delivery and organized at the Bio Barrier 2014 congress in Saarbrücken, Germany.
We are very pleased to announce that we will present the technology NativeSkin® at the 2nd Skin Metabolism Meeting.
Genoskin will present its technology NativeSkin® at the Cosminnov 2013 congress organized in Orléans, France on October 8th and 9th. Importantly, two of our partners,
We are very pleased to announce that our technology NativeSkin will be presented in a nice study done by LEO Pharma and us at the International Investigative Dermatology annual meeting (http://www.iid2013.org).